Cerevel Therapeutics, LLC   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Boston MA United States (2018)

Organization Overview

First Clinical Trial
2019
NCT04136873
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Cerevel Therapeutics, LLC